New Frontiers for Cartilage Repair and Protection

Cartilage

Volumn 3, Issue 1 SUPPL., 2012, Pages

  Zaslav, Kenneth ^a   McAdams, Timothy ^b   Scopp, Jason ^c   Theosadakis, Jason ^d   Mahajan, Vivek ^e   Gobbi, Alberto ^e  

^a Advanced Orthopedic Centers   (United States)

^b STANFORD UNIVERSITY   (United States)

^c Peninsula Orthopaedic Associates   (United States)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^e OASI Bioresearch Foundation   (Italy)

Author keywords

articular cartilage; cartilage repair; diagnosis; grafts; joint involved; knee; repair; scaffolds; sports injury; tissue

Indexed keywords

CHONDROITIN SULFATE; GLUCOSAMINE; HYALURONIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; BATROXOBIN; CHITOSAN; CHONDROITIN; COLLAGEN; PIASCLEDINE; POLYGLYCOLIC ACID; POLYLACTIC ACID;

ARTHROPLASTY; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CARTILAGE INJURY; CHONDROPATHY; CHONDROPROTECTION; DEBRIDEMENT; DIET SUPPLEMENTATION; ELECTROMAGNETIC FIELD; GENE THERAPY; HUMAN; HYALINE CARTILAGE; I ONE THERAPY; MESENCHYMAL STEM CELL TRANSPLANTATION; POSTOPERATIVE CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); THROMBOCYTE RICH PLASMA; VISCOSUPPLEMENTATION; ARTICULAR CARTILAGE; NONHUMAN; OSTEOARTHRITIS;

EID: 84875488889     PISSN: 19476035     EISSN: 19476043     Source Type: Journal    
DOI: 10.1177/1947603511411050     Document Type: Article

References (106)

1. Steadman JR,Briggs KK,Rodrigo JJ,Kocher MS,Gill TJ,Rodkey WG.Outcomes of microfracture for traumatic chondral defects of the knee: average 11-year follow-up.Arthroscopy. 2003;19 (5): 477-84.
2. Steadman JR,Miller BS,Karas SG,Schlegel TF,Briggs KK,Hawkins RJ.The microfracture technique in the treatment of full-thickness chondral lesions of the knee in National Football League players.J Knee Surg. 2003;16 (2): 83-6.
3. Peterson L,Minas T,Brittberg M,Nilsson A,Sjögren-Jansson E,Lindahl A.Two- to 9-year outcome after autologous chondrocyte transplantation of the knee.Clin Orthop Relat Res. 2000;374:212-34.
4. Peterson L,Brittberg M,Kiviranta I,Akerlund EL,Lindahl A.Autologous chondrocyte transplantation: biomechanics and long-term durability.Am J Sports Med. 2002;30 (1): 2-12.
5. Gomoll AH,Madry H,Knutsen G,van Dijk N,Seil R,Brittberg M, et al.The subchondral bone in articular cartilage repair: current problems in the surgical management.Knee Surg Sports Traumatol Arthrosc. 2010;18 (4): 434-47.
6. Richardson JBCartilage repair: current concepts. Brittberg MImhoff AMadry HMandelbaum B, ed. Guildford, UK: DJO Publications; 2010:53-9.
7. Morisset S,Frisbie DD,Robbins PD,Nixon AJ,McIlwraith CW.IL-1ra/IGF-1 gene therapy modulates repair of microfractured chondral defects.Clin Orthop Relat Res. 2007;462:221-8.
8. Lohmander LS.Articular cartilage and osteoarthrosis: the role of molecular markers to monitor breakdown, repair and disease.J Anat. 1994;184 (Pt 3): 477-92.
9. Iovu M,Dumais G,du Souich P.Anti-inflammatory activity of chondroitin sulfate.Osteoarthritis Cartilage. 2008;16 (Suppl 3): S14-8.
10. Campo GM,Avenoso A,Campo S,D'Ascola A,Traina P,Calatroni A.Chondroitin-4-sulphate inhibits NF-kB translocation and caspase activation in collagen-induced arthritis in mice.Osteoarthritis Cartilage. 2008;16 (12): 1474-83.
11. Piepoli T,Zanelli T,Letari O,Persiani S,Rovati LC,Caselli G.Glucosamine sulfate inhibits IL-1-stimulated gene expression at concentrations found in humans after oral intake [abstract].Arthritis Rheum. 2005;52 (Suppl 9): S502.
12. Alvarez-Soria MA,Largo R,Calvo E,Egido J,Herrer-Beaumont G.Differential anticatabolic profile of glucosamine sulfate versus other anti-osteoarthritic drugs on human osteoarthritic chondrocytes and synovial fibroblasts in culture.Osteoarthritis Cartilage. 2005;13:S153.
13. Dodge GR,Jimenez SA.Glucosamine sulfate modulates the levels of aggrecan and matrix metalloproteinase-3 synthesized by cultured human osteoarthritis articular chondrocytes.Osteoarthritis Cartilage. 2003;11 (6): 424-32.
14. Vallières M,du Souich P.Modulation of inflammation by chondroitin sulfate.Osteoarthritis Cartilage. 2010;18:S1-6.
15. Herrero-Beaumont G,Rovati LC,Castañeda S,Alvarez-Soria MA,Largo R.The reverse glucosamine sulfate pathway: application in knee osteoarthritis.Expert Opin Pharmacother. 2007;8 (2): 215-25.
16. Au RY,Al-Talib TK,Au AY,Phan PV,Frondoza CG.Avocado soybean unsaponifiables (ASU) suppress TNF-alpha, IL-1beta, COX-2, iNOS gene expression, and prostaglandin E2 and nitric oxide production in articular chondrocytes and monocyte/ macrophages.Osteoarthritis Cartilage. 2007;15 (11): 1249-55.
17. Henrotin YE,Labasse AH,Jaspar JM,De Groote DD,Zheng SX,Guillou GB, et al.Effects of three avocado/ soybean unsaponifiable mixtures on metalloproteinases, cytokines and prostaglandin E2 production by human articular chondrocytes.Clin Rheumatol. 1998;17 (1): 31-9.
18. Cinelli M,Guiducci S,Del Rosso A,Pignone A,Del Rosso M,Fibbi G, et al.Piascledine modulates the production of VEGF and TIMP-1 and reduces the invasiveness of rheumatoid arthritis synoviocytes.Scand J Rheumatol. 2006;35 (5): 346-50.
19. Cake MA,Read RA,Guillou B,Ghosh P.Modification of articular cartilage and subchondral bone pathology in an ovine meniscectomy model of osteoarthritis by avocado and soya unsaponifiables (ASU).Osteoarthritis Cartilage. 2000;8 (6): 404-11.
20. Boileau C,Martel-Pelletier J,Caron J,Msika P,Guillou GB,Baudouin C, et al.Protective effects of total fraction of avocado/soybean unsaponifiables on the structural changes in experimental dog osteoarthritis: inhibition of nitric oxide synthase and matrix metalloproteinase-13.Arthritis Res Ther. 2009;11 (2): R41.
21. Uebelhart D,Thonar EJ,Zhang J,Williams JM.Protective effect of exogenous chondroitin 4,6-sulfate in the acute degradation of articular cartilage in the rabbit.Osteoarthritis Cartilage. 1998;6:6-13.
22. Conrozier T.Chondroitin sulfates (CS 4&6): practical applications and economic impact.Presse Med. 1998;27 (36): 1866-8.
23. Appelboom T,Schuermans J,Verbruggen G,Henrotin Y,Reginster JY.Symptoms modifying effect of avocado/ soybean unsaponifiables (ASU) in knee osteoarthritis: a double blind, prospective, placebo-controlled study.Scand J Rheumatol. 2001;30 (4): 242-7.
24. Ernst E.Avocado-soybean unsaponifiables (ASU) for osteoarthritis: a systematic review.Clin Rheumatol. 2003;22 (4-5): 285-8.
25. Bruyere O,Pavelka K,Rovati LC,Deroisy R,Olejarova M,Gatterova J, et al.Glucosamine sulfate reduces osteoarthritis progression in postmenopausal women with knee osteoarthritis: evidence from two 3-year studies.Menopause. 2004;11 (2): 138-43.
26. Christensen R,Bartels EM,Astrup A,Bliddal H.Symptomatic efficacy of avocado-soybean unsaponifiables (ASU) in osteoarthritis (OA) patients: a meta-analysis of randomized controlled trials.Osteoarthritis Cartilage. 2008;16 (4): 399-408.
27. Towheed TE,Maxwell L,Anastassiades TP,Shea B,Houpt J,Robinson V, et al.Glucosamine therapy for treating osteoarthritis.Cochrane Database Syst Rev. 2005;2:.
28. Reichenbach S,Sterchi R,Scherer M,Trelle S,Bürgi E,Bürgi U, et al.Meta-analysis: chondroitin for osteoarthritis of the knee or hip.Ann Intern Med. 2007;146 (8): 580-90.
29. Hochberg MC,Zhan M,Langenberg P.The rate of decline of joint space width in patients with osteoarthritis of the knee: a systematic review and meta-analysis of randomized placebo-controlled trials of chondroitin sulfate.Curr Med Res Opin. 2008;24 (11): 3029-35.
30. Hochberg MC.Structure-modifying effects of chondroitin sulfate in knee osteoarthritis: an updated meta-analysis of randomized placebo-controlled trials of 2-year duration.Osteoarthritis Cartilage. 2010;18:S28-31.
31. Lee YH,Woo JH,Choi SJ,Ji JD,Song GG.Effect of glucosamine or chondroitin sulfate on the osteoarthritis progression: a meta-analysis.Rheumatol Int. 2010;30 (3): 357-63.
32. Pavelká K,Gatterová J,Olejarová M,Machacek S,Giacovelli G,Rovati LC.Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study.Arch Intern Med. 2002;162 (18): 2113-23.
33. Reginster JY,Deroisy R,Rovati LC,Lee RL,Lejeune E,Bruyere O, et al.Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial.Lancet. 2001;357 (9252): 251-6.
34. Michel BA,Stucki G,Frey D,De Vathaire F,Vignon E,Bruehlmann P, et al.Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: a randomized, controlled trial.Arthritis Rheum. 2005;52 (3): 779-86.
35. Kahan A,Uebelhart D,De Vathaire F,Delmas PD,Reginster JY.Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial.Arthritis Rheum. 2009;60 (2): 524-33.
36. Clegg DO,Reda DJ,Harris CL,Klein MA,O'Dell JR,Hooper MM, et al.Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.N Engl J Med. 2006;354 (8): 795-808.
37. Moskowitz Roland W.,Clegg Daniel O.,Theodosakis Jason J.,Felson David T. ACR State-of-the-Art: The Great Debate: Perspectives on Glucosamine Sulfate and Chondroitin Sulfate American College of Rheumatology annual meeting Washington, DC;
38. Watterson JR,Esdaile JM.Viscosupplementation: therapeutic mechanisms and clinical potential in osteoarthritis of the knee.J Am Acad Orthop Surg. 2000;8 (5): 277-84.
39. Kawasaki K,Ochi M,Uchio Y,Adachi N,Matsusaki M.Hyaluronic acid enhances proliferation and chondroitin sulfate synthesis in cultured chondrocytes embedded in collagen gels.J Cell Physiol. 1999;179 (2): 142-8.
40. Kujawa MJ,Caplan AI.Hyaluronic acid bonded to cell-culture surfaces stimulates chondrogenesis in stage 24 limb mesenchyme cell cultures.Dev Biol. 1986;114 (2): 504-18.
41. Yagishita K,Sekiya I,Sakaguchi Y,Shinomiya K,Muneta T.The effect of hyaluronan on tendon healing in rabbits.Arthroscopy. 2005;21 (11): 1330-6.
42. Waddell DD,Bert JM.The use of hyaluronan after arthroscopic surgery of the knee.Arthroscopy. 2010;26 (1): 105-11.
43. Greenberg DD,Stoker A,Kane S,Cockrell M,Cook JL.Biochemical effects of two different hyaluronic acid products in a co-culture model of osteoarthritis.Osteoarthritis Cartilage. 2006;14 (8): 814-22.
44. Wang CT,Lin YT,Chiang BL,Lin YH,Hou SM.High molecular weight hyaluronic acid down-regulates the gene expression of osteoarthritis-associated cytokines and enzymes in fibroblast-like synoviocytes from patients with early osteoarthritis.Osteoarthritis Cartilage. 2006;14 (12): 1237-47.
45. Mathies B.Effects of Viscoseal, a synovial fluid substitute, on recovery after arthroscopic partial meniscectomy and joint lavage.Knee Surg Sports Traumatol Arthrosc. 2006;14 (1): 32-9.
46. Goldberg VM,Buckwalter JA.Hyaluronans in the treatment of osteoarthritis of the knee: evidence for disease-modifying activity.Osteoarthritis Cartilage. 2005;13 (3): 216-24.
47. Strauss E,Schachter A,Frenkel S,Rosen J.The efficacy of intra-articular hyaluronan injection after the microfracture technique for the treatment of articular cartilage lesions.Am J Sports Med. 2009;37 (4): 720-6.
48. Díaz-Gallego L,Prieto JG,Coronel P,Gamazo LE,Gimeno M,Alvarez AI.Apoptosis and nitric oxide in an experimental model of osteoarthritis in rabbit after hyaluronic acid treatment.J Orthop Res. 2005;23 (6): 1370-6.
49. Hulmes DJ,Marsden ME,Strachan RK,Harvey RE,McInnes N,Gardner DL.Intra-articular hyaluronate in experimental rabbit osteoarthritis can prevent changes in cartilage proteoglycan content.Osteoarthritis Cartilage. 2004;12 (3): 232-8.
50. Mazzucco L,Balbo V,Cattana E,Guaschino R,Borzini P.Not every PRP-gel is born equal. Evaluation of growth factor availability for tissues through four PRP-gel preparations: Fibrinet, RegenPRP-Kit, Plateltex and one manual procedure.Vox Sang. 2009;97 (2): 110-8.
51. Bennett NT,Schultz GS.Growth factors and wound healing: biochemical properties of growth factors and their receptors.Am J Surg. 1993;165 (6): 728-37.
52. Molloy T,Wang Y,Murrell G.The roles of growth factors in tendon and ligament healing.Sports Med. 2003;33 (5): 381-94.
53. Anitua E,Sánchez M,Orive G,Andía I.The potential impact of the preparation rich in growth factors (PRGF) in different medical fields.Biomaterials. 2007;28 (31): 4551-60.
54. Mishra A,Pavelko T.Treatment of chronic elbow tendinosis with buffered platelet-rich plasma.Am J Sports Med. 2006;34 (11): 1774-8.
55. Sampson S,Gerhardt M,Mandelbaum B.Platelet rich plasma injection grafts for musculoskeletal injuries: a review.Curr Rev Musculoskelet Med. 2008;1 (3-4): 165-74.
56. Ares O,Cugat R.Biological repair of knee injuries in soccer players.Tech Knee Surg. 2010;9 (3): 132-8.
57. Kon E,Filardo G,Di Martino A,Marcacci M.Platelet-rich plasma (PRP) to treat sports injuries: evidence to support its use.Knee Surg Sports Traumatol Arthrosc. 2011;19 (4): 516-27.
58. Kon E,Mandelbaum BR.Prospective randomized study of PRP vs. HMW hyaluronic acid and LMW HA in arthritic knees.Arthroscopy.:.
59. De Mattei M,Fini M,Setti S,Ongaro A,Gemmati D,Stabellini G, et al.Proteoglycan synthesis in bovine articular cartilage explants exposed to different low-frequency low-energy pulsed electromagnetic fields.Osteoarthritis Cartilage. 2007;15 (2): 163-8.
60. De Mattei M,Caruso A,Pezzetti F,Pellati A,Stabellini G,Sollazzo V, et al.Effects of pulsed electromagnetic fields on human articular chondrocyte proliferation.Connect Tissue Res. 2001;42 (4): 269-79.
61. Varani K,Gessi S,Merighi S,Iannotta V,Cattabriga E,Spisani S, et al.Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils.Br J Pharmacol. 2002;136 (1): 57-66.
62. De Mattei M,Pasello M,Pellati A,Stabellini G,Massari L,Gemmati D, et al.Effects of electromagnetic fields on proteoglycan metabolism of bovine articular cartilage explants.Connect Tissue Res. 2003;44 (3-4): 154-9.
63. De Mattei M,Pellati A,Pasello M,Ongaro A,Setti S,Massari L, et al.Effects of physical stimulation with electromagnetic field and insulin growth factor-I treatment on proteoglycan synthesis of bovine articular cartilage.Osteoarthritis Cartilage. 2004;12 (10): 793-800.
64. Varani K,De Mattei M,Vincenzi F,Gessi S,Merighi S,Pellati A, et al.Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields.Osteoarthritis Cartilage. 2008;16 (3): 292-304.
65. De Mattei M,Varani K,Masieri FF,Pellati A,Ongaro A,Fini M, et al.Adenosine analogs and electromagnetic fields inhibit prostaglandin E(2) release in bovine synovial fibroblasts.Osteoarthritis Cartilage. 2009;17 (2): 252-62.
66. Fini M,Giavaresi G,Torricelli P,Cavani F,Setti S,Cane V, et al.Pulsed electromagnetic fields reduce knee osteoarthritis lesion progression in the aged Dunkin Hartley guinea pig.J Orthop Res. 2005;23 (4): 899-908.
67. Fini M,Torricelli P,Giavaresi G,Aldini NN,Cavani F,Setti S, et al.Effect of pulsed electromagnetic field stimulation on knee cartilage, subchondral and epiphyseal trabecular bone of aged Dunkin Hartley guinea pigs.Biomed Pharmacother. 2008;62 (10): 709-15.
68. Benazzo F,Cadossi M,Cavani F,Fini M,Giavaresi G,Setti S, et al.Cartilage repair with osteochondral autografts in sheep: effect of biophysical stimulation with pulsed electromagnetic fields.J Orthop Res. 2008;26 (5): 631-42.
69. Zorzi C,Dall'oca C,Cadossi R,Setti S.Effects of pulsed electromagnetic fields on patients' recovery after arthroscopic surgery: prospective, randomized and double-blind study.Knee Surg Sports Traumatol Arthrosc. 2007;15 (7): 830-4.
70. Benazzo F,Zanon G,Pederzini L,Modonesi F,Cardile C,Falez F, et al.Effects of biophysical stimulation in patients undergoing arthroscopic reconstruction of anterior cruciate ligament: prospective, randomized and double blind study.Knee Surg Sports Traumatol Arthrosc. 2008;16 (6): 595-601.
71. Simon TM,Jackson DW.Articular cartilage: injury pathways and treatment options.Sports Med Arthrosc. 2006;14 (3): 146-54.
72. Niederauer GG,Slivka MA,Leatherbury NC,Korvick DL,Harroff HH,Ehler WC, et al.Evaluation of multiphase implants for repair of focal osteochondral defects in goats. Biomaterials. 2000;21 (24): 2561-74.
73. Erggelet C,Endres M,Neumann K,Morawietz L,Ringe J,Haberstroh K, et al.Formation of cartilage repair tissue in articular cartilage defects pretreated with microfracture and covered with cell-free polymer-based implants.J Orthop Res. 2009;27 (10): 1353-60.
74. Hoemann CD,Hertig M,Rossomacha E,Sun J,Chevrier A,Shia MS, et al.Chitosan-glycerol phosphate/blood implants improve hyaline cartilage repair in ovine microfracture defects.J Bone Joint Surg Am. 2005;87:267-86.
75. Cartilage repair: current concepts. Kon EDelcogliano MMartino ADFilardo GNiceforo GZarba VBrittberg MImhoff AMadry HMandelbaum B, ed. Guildford, UK: DJO Publications; 2010:61-70.
76. Gravel M,Gross T,Vago R,Tabrizian M.Response of mesenchymal stem cells to chitosan-coralline composites microstructured using coralline as gas forming agent.Biomaterials. 2006;27:1899-906.
77. Scotti C,Buragas MS,Mangiavini L,Sosio C,Di Giancamillo A,Domeneghini C, et al.A tissue engineered osteochondral plug: an in vitro morphological evaluation.Knee Surg Sports Traumatol Arthrosc. 2007;15 (11): 1363-9.
78. TiGenix. A prospective, post-marketing registry on the use of ChondroMimetic for the repair of osteochondral defects. Available from: http://clinicaltrials.gov/ct2/show/NCT01209390.
79. Ahmed TA,Hincke MT.Strategies for articular cartilage lesion repair and functional restoration.Tissue Eng Part B Rev. 2010;16 (3): 305-29.
80. Bedi A,Williams R.Cartilage resurfacing using synthetic composite plugs.Tech Knee Surg. 2009;8 (1): 29-36.
81. Williams RJ,Gamradt SC.Articular cartilage repair using a resorbable matrix scaffold.Instr Course Lect. 2008;57:563-71.
82. Mithoefer K,McAdams TR,Scopp JM,Mandelbaum BR.Emerging options for treatment of articular cartilage injury in the athlete.Clin Sports Med. 2009;28 (1): 25-40.
83. Lu Y,Dhanaraj S,Wang Z,Bradley DM,Bowman SM,Cole BJ, et al.Minced cartilage without cell culture serves as an effective intraoperative cell source for cartilage repair.J Orthop Res. 2006;24 (6): 1261-70.
84. Steinwachs MR,Guggi T,Kreuz PC.Marrow stimulation techniques.Injury. 2008;39:S26-31.
85. Caplan AI.Why are MSCs therapeutic? New data: new insight.J Pathol. 2009;217 (2): 318-24.
86. Caplan AI.Review: mesenchymal stem cells. Cell-based reconstructive therapy in orthopedics.Tissue Eng. 2005;11 (7-8): 1198-211.
87. Caplan AI,Dennis JE.Mesenchymal stem cells as trophic mediators.J Cell Biochem. 2006;98 (5): 1076-84.
88. Fortier LA,Balkman CE,Sandell LJ,Ratcliffe A,Nixon AJ.Insulin-like growth factor-I gene expression patterns during spontaneous repair of acute articular cartilage injury.J Orthop Res. 2001;19 (4): 720-8.
89. Fortier LA,Mohammed HO,Lust G,Nixon AJ.Insulin-like growth factor-I enhances cell-based repair of articular cartilage.J Bone Joint Surg Br. 2002;84 (2): 276-88.
90. Jones E,McGonagle D.Human bone marrow mesenchymal stem cells in vivo.Rheumatology (Oxford). 2008;47 (2): 126-31.
91. Robey PG,Bianco P.The use of adult stem cells in rebuilding the human face.J Am Dent Assoc. 2006;137 (7): 961-72.
92. Wang L,Li Y,Chen X,Chen J,Gautam SC,Xu Y, et al.MCP-1, MIP-1, IL-8 and ischemic cerebral tissue enhance human bone marrow stromal cell migration in interface culture.Hematology. 2002;7 (2): 113-7.
93. Gobbi A,Karnatzikos G,Scotti C,Mahajan V,Mazzucco L,Grigolo B.One-step cartilage repair with bone marrow aspirate concentrated cells and collagen matrix in full-thickness knee cartilage lesions: results at 2-year follow-up.Cartilage. 2011;:.
94. Peterson L,Vasiliadis HS,Brittberg M,Lindahl A.Autologous chondrocyte implantation: a long-term follow-up.Am J Sports Med. 2010;38 (6): 1117-24.
95. Chubinskaya S,Hurtig M,Rueger DC.OP-1/BMP-7 in cartilage repair.Int Orthop. 2007;31 (6): 773-81.
96. Luyten FP,Tylzanowski P,Lories RJ.Wnt signaling and osteoarthritis.Bone. 2009;44 (4): 522-7.
97. Tuli R,Tuli S,Nandi S,Huang X,Manner PA,Hozack WJ, et al.Transforming growth factor-beta-mediated chondrogenesis of human mesenchymal progenitor cells involves N-cadherin and mitogen-activated protein kinase and Wnt signaling cross-talk.J Biol Chem. 2003;278 (42): 41227-36.
98. Bajada S,Marshall MJ,Wright KT,Richardson JB,Johnson WE.Decreased osteogenesis, increased cell senescence and elevated Dickkopf-1 secretion in human fracture non union stromal cells.Bone. 2009;45 (4): 726-35.
99. Steinert AF,Palmer GD,Ghivizzani SCCartilage injury in the athlete. Mirzayan R, ed. New York: Thieme; 2006:297-308.
100. Lee EH,Hui JH.The potential of stem cells in orthopaedic surgery.J Bone Joint Surg Br. 2006;88 (7): 841-51.
101. Hui JH,Chen F,Thambyah A,Lee EH.Treatment of chondral lesions in advanced osteochondritis dissecans: a comparative study of the efficacy of chondrocytes, mesenchymal stem cells, periosteal graft, and mosaicplasty (osteochondral autograft) in animal models.J Pediatr Orthop. 2004;24 (4): 427-33.
102. Yan H,Yu C.Repair of full-thickness cartilage defects with cells of different origin in a rabbit model.Arthroscopy. 2007;23 (2): 178-87.
103. Liu Y,Shu XZ,Prestwich GD.Osteochondral defect repair with autologous bone marrow-derived mesenchymal stem cells in an injectable, in situ, cross-linked synthetic extracellular matrix.Tissue Eng. 2006;12 (12): 3405-16.
104. Dragoo JL,Samimi B,Zhu M,Hame SL,Thomas BJ,Lieberman JR, et al.Tissue-engineered cartilage and bone using stem cells from human infrapatellar fat pads.J Bone Joint Surg Br. 2003;85 (5): 740-7.
105. Dragoo JL,Carlson G,McCormick F,Khan-Farooqi H,Zhu M,Zuk PA, et al.Healing full-thickness cartilage defects using adipose-derived stem cells. Tissue Eng. 2007;13 (7): 1615-21.
106. Grande DA,Mason J,Light E,Dines D.Stem cells as platforms for delivery of genes to enhance cartilage repair.J Bone Joint Surg Am. 2003;85-A:111-6.